AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 59 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $27,829,000 | +179.1% | 1,360,818 | +104.7% | 0.01% | +150.0% |
Q3 2016 | $9,971,000 | +48.0% | 664,746 | +6.8% | 0.00% | +100.0% |
Q2 2016 | $6,736,000 | +86.3% | 622,563 | +133.5% | 0.00% | 0.0% |
Q1 2016 | $3,615,000 | -30.3% | 266,606 | -5.1% | 0.00% | 0.0% |
Q4 2015 | $5,184,000 | -22.9% | 280,954 | +5.7% | 0.00% | -50.0% |
Q3 2015 | $6,728,000 | – | 265,713 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 1,240,000 | $25,966,000 | 57.34% |
Foresite Capital Management II, LLC | 2,605,499 | $54,559,000 | 11.53% |
Foresite Capital Management III, LLC | 611,893 | $12,813,000 | 4.89% |
Palo Alto Investors LP | 3,471,740 | $72,698,000 | 4.84% |
SANDERS MORRIS HARRIS LLC | 486,906 | $10,196,000 | 2.47% |
Eventide Asset Management | 3,084,000 | $64,579,000 | 2.13% |
Sofinnova Investments, Inc. | 346,770 | $7,261,000 | 0.66% |
EMERALD ADVISERS, LLC | 610,511 | $12,784,000 | 0.60% |
RICE HALL JAMES & ASSOCIATES, LLC | 752,358 | $15,754,000 | 0.56% |
EMERALD MUTUAL FUND ADVISERS TRUST | 587,464 | $12,301,000 | 0.54% |